BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18338752)

  • 1. Cervical cancer screening program integrating Pap smear and HPV DNA testing: a population-based study.
    Chao A; Hsu KH; Lai CH; Huang HJ; Hsueh S; Lin SR; Jung SM; Chao FY; Huang SL; Huang CC; Yang JE; Chang TC
    Int J Cancer; 2008 Jun; 122(12):2835-41. PubMed ID: 18338752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.
    Chow IH; Tang CH; You SL; Liao CH; Chu TY; Chen CJ; Chen CA; Pwu RF
    Br J Cancer; 2010 Dec; 103(12):1773-82. PubMed ID: 21102588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study].
    Kahng J; Lee HJ
    Korean J Lab Med; 2008 Feb; 28(1):70-8. PubMed ID: 18309258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 korean women determined by DNA chip.
    Hwang HS; Park M; Lee SY; Kwon KH; Pang MG
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2153-6. PubMed ID: 15598774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.
    Jacobs MV; Zielinski D; Meijer CJ; Pol RP; Voorhorst FJ; de Schipper FA; Runsink AP; Snijders PJ; Walboomers JM
    Br J Cancer; 2000 Apr; 82(8):1421-6. PubMed ID: 10780521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
    Wallin KL; Wiklund F; Luostarinen T; Angström T; Anttila T; Bergman F; Hallmans G; Ikäheimo I; Koskela P; Lehtinen M; Stendahl U; Paavonen J; Dillner J
    Int J Cancer; 2002 Oct; 101(4):371-4. PubMed ID: 12209962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
    Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
    Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study of Cytology and Histopathology of Cervical Lesion in VIA Positive Patients and Its Correlation with High Risk Human Papilloma Virus.
    Ansari NP; Saleh FM; Shahida SM; Rahman EN
    Mymensingh Med J; 2017 Jul; 26(3):505-513. PubMed ID: 28919602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is the PAP smear era coming to an end?].
    Nowak-Markwitz E; Spaczyński M
    Ginekol Pol; 2015 Dec; 86(12):947-50. PubMed ID: 26995946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under-screening in Taiwan.
    Chou HH; Huang HJ; Cheng HH; Chang CJ; Yang LY; Huang CC; Chang WY; Hsueh S; Chao A; Wang CJ; Tang YH; Lin CT; Qiu JT; Chen MY; Chen CY; Huang KG; Tsai TC; Chang TC; Lai CH
    J Formos Med Assoc; 2016 Dec; 115(12):1089-1096. PubMed ID: 26723863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening.
    Morisada T; Saika K; Saito E; Kono K; Saito H; Aoki D
    Jpn J Clin Oncol; 2018 May; 48(5):495-498. PubMed ID: 30535331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan.
    Lai CH; Chao A; Chang CJ; Chao FY; Huang HJ; Hsueh S; Lin CT; Cheng HH; Huang CC; Yang JE; Wu TI; Chou HH; Chang TC
    Int J Cancer; 2008 Oct; 123(7):1685-92. PubMed ID: 18623128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between cervical inflammation and histologic evidence of HPV in PAP smears and adverse pregnancy outcome in low risk population.
    Nimrodi M; Kleitman V; Wainstock T; Gemer O; Meirovitz M; Maymon E; Benshalom-Tirosh N; Erez O
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():160-165. PubMed ID: 29727786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in Germany.
    Sheriff SK; Petry KU; Ikenberg H; Crouse G; Mazonson PD; Santas CC
    Eur J Health Econ; 2007 Jun; 8(2):153-60. PubMed ID: 17308921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.
    Cárdenas-Turanzas M; Nogueras-Gonzalez GM; Scheurer ME; Adler-Storthz K; Benedet JL; Beck JR; Follen M; Cantor SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2865-71. PubMed ID: 18843032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.